SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The board of directors declared a quarterly distribution of $0.25 per share ($1.00 annualized) for American Healthcare REIT shareholders. This distribution declaration is material to investors as it affects shareholder returns and capital allocation expectations, though it does not fit the more specific 8-K event categories.
View raw filing on EDGAR →Stockholders voted at the June 16, 2026 Annual Meeting on four proposals: election of Class I directors (Herring, Kidd, Rudow), ratification of RSM US LLP as independent auditor, advisory approval of named executive officer compensation, and approval of the 2026 Equity Incentive Plan. All proposals received shareholder approval with tabulated voting results disclosed.
View raw filing on EDGAR →Andrew C. Carington departed Hamilton Beach Brands as Senior Vice President, General Counsel and Secretary, effective immediately on June 18, 2026. The departure of a senior executive holding the General Counsel position—a key officer responsible for legal and governance matters—is material to investors' assessment of the company's leadership and operational continuity.
View raw filing on EDGAR →Sean Rowles was appointed as Chief Risk Officer effective June 17, 2026, to lead Oportun's risk and credit functions, succeeding Patrick Kirscht who departed after 18 years in the Chief Credit Officer role.
View raw filing on EDGAR →Universal Insurance Holdings entered into Note Purchase Agreements on June 16, 2026, to issue and sell $100 million of 7.75% Senior Unsecured Notes due 2031 in a private placement. The company used proceeds to redeem all outstanding 2026 Notes on June 17, 2026, at par plus accrued interest, representing a material refinancing and capital structure transaction.
View raw filing on EDGAR →Standard Biotools held its Annual Meeting of Stockholders on April 24, 2026, with stockholders voting on five proposals: election of three Class I directors (Michael Egholm, Thomas Carey, and Eli Casdin), advisory approval of executive compensation, ratification of PricewaterhouseCoopers LLP as independent auditor, approval of the 2026 Equity Incentive Plan, and approval of an amendment to the 2017 Employee Stock Purchase Plan. All proposals passed with substantial majorities.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder voting results from PJT Partners' 2026 Annual Meeting held on June 18, 2026. The filing presents final vote tallies for three proposals: director elections (K. Don Cornwell, Peter L.S. Currie, Thomas M. Ryan), advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. All three proposals passed with substantial majorities, making this a routine but material governance disclosure that investors rely upon to confirm board composition and audit firm appointment.
View raw filing on EDGAR →This exhibit is a notice of partial redemption of US$165 million of Studio City Finance Limited's US$500 million 6.500% Senior Notes due 2028. While technically a redemption (retirement) of existing debt rather than issuance of new debt, it represents a material modification of the registrant's direct financial obligations and capital structure. The redemption on July 18, 2026 at par plus accrued interest is a significant financial event affecting debt outstanding. This is classified as debt_issuance under the broader category of "creation of a new direct financial obligation" or material debt activity, though a redemption is technically the inverse; the closest fit is debt_issuance as it involves a material debt transaction, though financial_other could also apply.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from SAB Biotherapeutics' 2026 Annual Meeting of Stockholders held on June 18, 2026. The filing reports the outcomes of two proposals: (1) election of four Class II directors (David Zaccardelli, David Link, Katie Ellias, and Andrew Moin) with detailed vote tallies, and (2) ratification of EisnerAmper LLP as independent auditor. The disclosure includes quorum information (76.12% attendance) and complete voting results for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →BCB Bancorp's Board voted to suspend quarterly cash dividends on common and preferred stock and suspend its dividend reinvestment plan, citing the need for capital preservation during a "fulsome evaluation of the Bank's credit portfolios." The CEO explicitly states this decision is to preserve the Bank's "well-capitalized" position, signaling underlying credit or capital concerns. While dividend suspension is material to investors, it does not fit neatly into the more specific event categories (not a restatement, going-concern disclosure, covenant breach, or impairment charge), making "other_material" the most appropriate classification.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from a special meeting held on June 18, 2026. The filing reports the final voting tallies on Proposal 1 authorizing the Company to issue common stock below net asset value (NAV), with detailed vote counts for and against. This authorization to issue dilutive equity is material to investors as it affects potential share dilution and the Company's capital structure.
View raw filing on EDGAR →Caroline Tsai, Chief Legal & Corporate Affairs Officer and Corporate Secretary, is stepping down effective July 1, 2026. While the filing also discloses Chip Keller's appointment as Chief Legal Officer, the primary disclosed action centers on Ms. Tsai's departure after four years with the company. The filing emphasizes her role in major transactions (Worldpay divestiture and TSYS acquisition), making her departure material to investors.
View raw filing on EDGAR →Contango held its 2026 Annual Meeting of Stockholders on June 18, 2026, at which all seven director nominees were elected, Baker Tilly US, LLP was ratified as auditor, and non-binding advisory votes on executive compensation and say-on-pay frequency (annual) were approved.
View raw filing on EDGAR →Vishwas Setia's separation as Chief Financial Officer is the primary disclosed action, effective immediately following an HR violation review. While Jonathan Gillis's appointment as interim CFO is also disclosed, the filing centers on Setia's departure and the circumstances surrounding it (separation agreement, COBRA coverage). The CFO role is a named executive officer position material to investors' assessment of the company's financial leadership and governance.
View raw filing on EDGAR →Atmos Energy completed a $700 million public offering of senior notes on June 18, 2026, disclosed under Item 1.01 (Entry into a Material Definitive Agreement). While this is a debt issuance rather than a traditional M&A transaction, Item 1.01 encompasses material definitive agreements including significant financing activities. The $693.9 million in net proceeds represents a material capital transaction that would affect investor assessment of the company's financial position and capital structure. However, this is more accurately characterized as a material financing event than M&A activity proper.
View raw filing on EDGAR →Faeth Therapeutics entered into an at-the-market (ATM) offering agreement with TD Securities on June 18, 2026, authorizing the sale of up to $150 million in common stock shares, representing a classic dilutive equity issuance that signals potential capital needs and future shareholder dilution.
View raw filing on EDGAR →Automatic conversion of 24,435.594 shares of Series B Non-Voting Convertible Preferred Stock into 24,435,594 shares of Common Stock materially increased the outstanding share count to 25,778,754 shares, resulting in significant dilution to existing shareholders' ownership percentages and earnings per share.
View raw filing on EDGAR →Jaguar Health entered into multiple material definitive agreements on June 17-18, 2026, including amendments to royalty interests and promissory notes with Streeterville and Uptown Capital, as well as three exchange transactions converting Series Q Preferred Stock into common stock. These transactions represent a significant restructuring of the Company's capital structure.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from IonQ's 2026 Annual Meeting of Stockholders held on June 16, 2026, covering three proposals: election of Class II directors (Kathryn K. Chou and William F. Scannell), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents final voting tallies for each proposal, which is the quintessential content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →JM Manufacturing, a wholly owned subsidiary of JM Group Limited, issued a promissory note on June 5, 2026 to the Company's CEO and major shareholder Chun Kwok Stanley Ting for a principal amount of up to HK$15,065,000 due May 31, 2033. This constitutes creation of a new direct financial obligation (debt instrument) by the registrant, fitting the debt_issuance category. The transaction is material as it represents a significant financing arrangement with a related party (the CEO/Chairman) and affects the company's capital structure and obligations.
View raw filing on EDGAR →The press release announces Robo.ai's entry into an agreement to acquire 100% of QC Capital Limited for US$60 million in newly issued Class B ordinary shares, with closing expected within 30 business days. This is a material acquisition transaction that would significantly affect investor assessment of the registrant's strategic direction, capital allocation, and future revenue prospects. The disclosure explicitly describes it as a "proposed acquisition" and "strategic step" in the company's development.
View raw filing on EDGAR →RYTHM held its 2026 Annual Meeting of Stockholders on June 16, 2026, with voting results on three proposals: election of seven directors, ratification of GuzmanGray as independent auditor, and approval of an amendment to the 2022 Omnibus Equity Incentive Plan increasing available shares by 115,000.
View raw filing on EDGAR →Chicago Atlantic Real Estate Finance, Inc. (REFI) and Chicago Atlantic BDC, Inc. (LIEN) entered into a definitive merger agreement whereby REFI will merge into LIEN in an all-stock strategic combination. REFI stockholders will receive LIEN shares based on an NAV-for-NAV exchange ratio, resulting in REFI stockholders owning approximately 50.5% of the combined company post-closing. The transaction requires stockholder approval from both companies and is expected to close in Q4 2026.
View raw filing on EDGAR →Chicago Atlantic Real Estate Finance, Inc. (REFI) entered into a definitive merger agreement on June 17, 2026, to merge with and into Chicago Atlantic BDC, Inc. (LIEN), with LIEN as the surviving entity. The all-stock, NAV-for-NAV strategic combination creates a combined platform with pro-forma NAV of $613 million and portfolio of $771 million, subject to stockholder approval and expected to close in Q4 2026.
View raw filing on EDGAR →TGE's Board has approved a share repurchase program authorizing up to US$10 million in ordinary share repurchases, which constitutes a return of capital to shareholders. While the announcement also includes a voluntary lock-up commitment by the controlling shareholder (AMTD Digital) and management, the primary material disclosure is the share repurchase authorization. This is material as it signals capital allocation policy and board confidence in valuation, and would affect a reasonable investor's assessment of shareholder returns and capital management strategy.
View raw filing on EDGAR →Clearmind announced the grant of U.S. Patent No. 12,350,242 for "Binge Behavior Regulators" covering its molecule MEAI, bringing its total granted patent portfolio to 32 patents across 19 families. For a clinical-stage biotech company, patent grants are operationally significant milestones that strengthen IP protection for lead candidates like CMND-100 and support competitive positioning in psychedelic-based therapeutics. While not a specific named event type, this is a material operational/strategic disclosure affecting the company's intellectual property position and development pipeline.
View raw filing on EDGAR →This Item 7.01 disclosure announces an updated investor presentation posted to the company's website on June 17, 2026. The presentation contains material forward-looking statements regarding the pending Canyon Creek acquisition, anticipated dividend increases from $1.35 to $1.50 per share post-close, a $1.0Bn Goldman Sachs ABS Warehouse Facility, and a $15Bn acquisition pipeline. While the presentation itself is furnished (not filed) under Regulation FD, the substantive disclosures—particularly the acquisition economics, financing arrangements, and dividend guidance—constitute material updates to investors about the company's strategic direction and financial outlook. This does not fit neatly into the more specific event categories (it is not an earnings release, M&A completion, or compensation arrangement), but the forward-looking guidance and acquisition-related disclosures are material to a reasonable investor's assessment of the registrant.
View raw filing on EDGAR →The exhibit announces a share repurchase program approved by TGE's Board of Directors authorizing repurchases of up to US$10 million of ordinary shares, which constitutes a return of capital to shareholders. While the announcement also includes a voluntary lock-up commitment by the controlling shareholder (AMTD Digital Inc.) and management, the primary disclosed action is the share repurchase authorization, which falls under dividend_distribution as a capital return mechanism. The repurchase is material as it signals board confidence in valuation and affects shareholder value.
View raw filing on EDGAR →Megan Holdings Ltd. disclosed a proxy statement and notice of annual general meeting scheduled for July 13, 2026, seeking shareholder approval for three proposals: (1) authorization for a share consolidation (up to 1-for-400) to address Nasdaq minimum bid price requirements, (2) amendments to the memorandum and articles of association to shorten meeting notice periods and post-service timing, and (3) an adjournment proposal. The share consolidation is material as it directly addresses Nasdaq listing compliance and would significantly alter the company's share structure.
View raw filing on EDGAR →NewGen has executed an agreement for a US$4 million strategic investment in K25.ai, completing a US$10 million Pre-A round and increasing NewGen's aggregate ownership to 10%. This represents a material acquisition of a significant equity stake in an external company, coupled with exclusive Asia-Pacific agency rights. The transaction is disclosed as a strategic milestone and would materially affect a reasonable investor's assessment of NewGen's capital deployment and portfolio composition.
View raw filing on EDGAR →Sagtec Global Limited issued 1,500,000 Class A Ordinary Shares to CEO and major shareholder Ng Chen Lok at US$1.04 per share (US$1.56 million aggregate) in a private placement of unregistered, restricted securities with no registration rights.
View raw filing on EDGAR →Sagtec Global provided FY2026 financial guidance (35% revenue growth, 22% net profit growth), announced strategic expansion of its Malaya Heritage F&B business with four new outlet openings, and disclosed approximately US$3.0 million in secured project backlog expected to be recognized.
View raw filing on EDGAR →The exhibit announces a share repurchase program approved by TGE's Board of Directors authorizing repurchases of up to US$10 million of ordinary shares. While the primary focus is the repurchase program, the announcement also discloses a voluntary lock-up commitment by the controlling shareholder (AMTD Digital Inc.), directors, and management for two years. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution category. The Board's stated rationale—that shares are "drastically undervalued" and the program is "intended to enhance shareholder value"—indicates material significance to investors assessing the company's capital allocation and management confidence.
View raw filing on EDGAR →Ondas Inc. entered into a definitive agreement to acquire Cyberhawk Holdings Limited in a material acquisition valued at approximately $125 million, structured as ~95% cash and 5% equity, with expected close in Q3 2026. The transaction expands Ondas into critical infrastructure intelligence with $45M+ expected revenue and $95M backlog.
View raw filing on EDGAR →Ms. Liu Liangping resigned from her position as Director of the Board effective immediately on June 18, 2026. Although she retains her COO role and other subsidiary positions, the departure from the Board constitutes a material executive departure. The stated reason—to devote herself to M&A projects—and the explicit statement that the resignation is not due to disagreement suggest an orderly transition, but Board-level departures are material to investors assessing governance and leadership continuity.
View raw filing on EDGAR →The press release announces that Luda Technology Group Limited has signed a memorandum of understanding (MOU) to acquire 55% shares in Asia AI Data Centre & Quantum Technology Company Limited for USD 400,000 in cash plus USD 535,000 in ordinary shares. This represents a material acquisition activity marking the company's strategic entry into the data centre and AI computing infrastructure industry, a significant diversification from its core stainless steel and carbon steel flanges business. The transaction involves a related party (Ms. Liu Liangping, the COO and spouse of CEO Mr. Ma Biu) and is explicitly characterized as transforming the company's data centre strategy "from exploration into execution."
View raw filing on EDGAR →Cadrenal announced plans to submit a Rare Pediatric Disease Designation (RPDD) request to the FDA for tecarfarin in Kawasaki disease, which if granted would make the company eligible for a Priority Review Voucher valued at $180–$205 million. The company also disclosed a dual-track portfolio strategy representing a material strategic and regulatory development affecting investor expectations around value creation and capital efficiency.
View raw filing on EDGAR →Lion Group Holding Ltd. entered into a Memorandum of Understanding on June 18, 2026, for the potential acquisition of 100% of Aquila Hash, Inc., a Delaware corporation. Although the MOU is non-binding except for customary provisions and contemplates future negotiation of definitive terms, the entry into a material acquisition agreement—even in preliminary form—is a reportable M&A activity event. The disclosure explicitly identifies this as a potential acquisition transaction and establishes a 60-day exclusivity and due diligence period, signaling serious intent and materiality to investors.
View raw filing on EDGAR →BiomX disclosed a strategic transition to a defense and security technology holding company and posted an updated investor presentation reflecting this repositioning. While Item 7.01 (Regulation FD Disclosure) is typically used for routine informational updates, the substance here—a completed "fundamental strategic transition" away from legacy clinical-stage biotech activities—is material to investors' understanding of the company's business model, portfolio, and strategy. The press release and presentation emphasize real deployments, customer relationships (Elbit Systems, Rafael), and a new operating framework (Detection-Analysis-Response), which would affect a reasonable investor's assessment. However, this does not fit neatly into the specific event-type taxonomy (not M&A, not an executive change, not a restatement or impairment), so "other_material" is most appropriate.
View raw filing on EDGAR →The disclosure announces the commencement of separate trading of Class A Ordinary Shares and Warrants from Units following the Company's IPO completed on June 4, 2026. This is a routine post-IPO administrative event related to unit separation and listing mechanics. While it affects the trading structure of the Company's securities, it does not fit neatly into the more specific event categories (not an earnings release, executive change, M&A activity, impairment, covenant breach, or other defined material events). The event is material to investors as it affects how the Company's securities trade, but it is primarily a procedural/administrative disclosure rather than a substantive business or financial event.
View raw filing on EDGAR →MSP Recovery disclosed entry into a discretionary $0.1 million advance from Hazel Partners under an existing working capital facility on June 11-12, 2026. The filing emphasizes that the facility is entirely discretionary with no committed liquidity, no borrowing base, and no obligation to fund. Critically, the company explicitly states "no remaining funding capacity was available under the facility" as of Q3-2025, and this advance is a "one-time" accommodation that "does not reinstate, replenish, or otherwise reopen availability." The company's repeated cautions that this should not be viewed as indicative of future funding availability, combined with the exhaustion of prior capacity and reliance on discretionary advances for operating expenses, signals financial stress and potential covenant concerns or technical defaults that prompted Hazel's discretionary accommodation.
View raw filing on EDGAR →This is a monthly operational and production update disclosing material business metrics and strategic progress. The exhibit reports significant operational achievements: Bitcoin production of 921 BTC (up 370% Y/Y), self-mining hash rate of 70.2 EH/s, AI Cloud ARR of ~$69M at 90% utilization, and advancement of major infrastructure projects (Tydal, Norway colocation negotiations in "advanced stages," GB300 cluster deployment). These metrics and strategic milestones would affect a reasonable investor's assessment of the company's operational execution and growth trajectory, particularly given the company's focus on AI and Bitcoin mining infrastructure. While not fitting a specific named category (not earnings, not M&A, not a discrete event), the disclosure is clearly operational and material to the registrant's business performance.
View raw filing on EDGAR →Globavend entered into a Standby Equity Purchase Agreement (SEPA) on June 16, 2026, with YA II PN, Ltd. for the purchase of up to $20 million of ordinary shares over 36 months. This is a committed equity financing arrangement where the company can draw down capital by issuing shares at a discount to market price (93–96% of VWAP), subject to registration. The structure and mechanics—discretionary advances, volume-weighted pricing, and a $20 million commitment—are characteristic of a PIPE-like dilutive equity issuance used to raise capital.
View raw filing on EDGAR →Katherine Rubenstein departed her role as Chief Operating Officer of Blackstone Secured Lending Fund on June 15, 2026, to pursue other opportunities. The disclosure explicitly states this was not due to any disagreement with the Fund's operations or policies. This is a straightforward executive departure of a named officer, material to investors assessing the Fund's management continuity and operational leadership.
View raw filing on EDGAR →Katherine Rubenstein departed her role as Chief Operating Officer of Blackstone Private Credit Fund on June 15, 2026. The disclosure explicitly states her departure was not due to disagreement with the Fund's operations or policies. This is a straightforward executive departure of a named officer, filed under Item 5.02, and is material as it involves a senior operational executive leaving the organization.
View raw filing on EDGAR →SS Innovations entered into an ATM Sales Agreement with Virtu Americas LLC on June 18, 2026, to sell up to $50 million of common stock through an "at the market offering" program. This is a classic dilutive equity issuance that would materially affect existing shareholders through potential dilution and is a significant capital-raising activity for the company.
View raw filing on EDGAR →The filing discloses the resignation of three directors (Meghji, Fader-Rattner, Perkal) and three principal officers effective June 18, 2026: CEO Robert Rivas Collins, CFO Eric Greenhaus, and COO Matthew Perkal. While the filing also includes appointments of Chinh Chu as principal executive officer and Thomas Boychuk as CFO, the dominant narrative centers on the departures of key leadership. The simultaneous departure of the CEO, CFO, and COO, along with three board members, represents a material change in control and governance structure that would affect a reasonable investor's assessment of the company.
View raw filing on EDGAR →Palmer Square Capital BDC Inc. disclosed the pricing of a $300 million term debt securitization refinancing (CLO Reset Transaction) through its subsidiary Palmer Square BDC CLO 1, Ltd., expected to close July 15, 2026. While technically a refinancing rather than a traditional M&A transaction, this represents a material capital structure event involving the issuance of $228 million AAA Class A Notes and $72 million AA Class B Notes, which materially affects the company's financing obligations and capital structure. The transaction is disclosed under Item 7.01 (Regulation FD Disclosure) rather than a dedicated M&A item, but the substance—a significant debt refinancing affecting the company's financial position—qualifies as material activity.
View raw filing on EDGAR →INLIF announces a strategic entry into the humanoid robotics market, representing a material expansion of the company's business scope beyond its traditional injection molding machine manipulator arms. The announcement discloses R&D commencement in H1 2026, prototype testing with claimed high-dynamic motion capabilities, and four strategic initiatives for commercialization.
View raw filing on EDGAR →INLIF announces completion of delivery and commercial acceptance of its first order of battery cell packing machines worth approximately $4.4 million USD (RMB 30 million), along with a follow-on order for six additional units and management's estimate of up to 50 units by end-2026 (approximately $14.7 million), representing a material operational and strategic milestone in the company's transition into industrialization of new energy equipment.
View raw filing on EDGAR →